The prevention of heart failure--a new agenda.

Suppr

超能文献

作者信息

Cohn J N

出版信息

N Engl J Med. 1992 Sep 3;327(10):725-7. doi: 10.1056/NEJM199209033271010.

DOI:10.1056/NEJM199209033271010

PMID:1495526

Abstract

摘要

相似文献

The prevention of heart failure--a new agenda.

N Engl J Med. 1992 Sep 3;327(10):725-7. doi: 10.1056/NEJM199209033271010.

[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].

Ital Heart J Suppl. 2005 Dec;6(12):769-79.

ACE inhibitors after myocardial infarction.

Br J Clin Pract. 1995 Jul-Aug;49(4):171.

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

Prescrire Int. 2005 Oct;14(79):180-6.

Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.

Am Heart J. 2004 Aug;148(2):356-64. doi: 10.1016/j.ahj.2004.02.011.

Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.

Blood Press Suppl. 1995;1:1-45.

[Do ACE inhibitors help prevent heart failure? Results of 3 clinical trials].

Ned Tijdschr Geneeskd. 1993 Jan 23;137(4):173-6.

A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.

Cent Afr J Med. 1996 Aug;42(8):253-5.

Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.

Am Heart J. 2003 Jun;145(6):E21. doi: 10.1016/S0002-8703(03)00109-1.

[Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].

Ital Heart J Suppl. 2003 Aug;4(8):623-34.

引用本文的文献

Prevalence and Prognostic Value of Heart Failure Stages: An Elderly Inpatient Based Cohort Study.

Front Med (Lausanne). 2021 Apr 22;8:639453. doi: 10.3389/fmed.2021.639453. eCollection 2021.

Pharmacological management of chronic heart failure in adults: a review of the literature.

Malawi Med J. 2004 Mar;16(1):22-6.

Heart failure is preventable.

Curr Heart Fail Rep. 2010 Sep;7(3):91-2. doi: 10.1007/s11897-010-0015-7.

[Diabetes and heart failure].

Herz. 2010 May;35(3):140-6. doi: 10.1007/s00059-010-3337-z.

The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma.

Cell Mol Life Sci. 2004 Jan;61(1):118-28. doi: 10.1007/s00018-003-3337-8.

The role of brain natriuretic peptide in population screening.

Heart Fail Rev. 2003 Oct;8(4):349-54. doi: 10.1023/a:1026143231117.

Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients?

Br J Gen Pract. 2000 Sep;50(458):735-42.

Comparison of captopril and ibopamine in mild to moderate heart failure.

Heart. 1997 Sep;78(3):285-90. doi: 10.1136/hrt.78.3.285.

Changing patterns of investigation and treatment of cardiac failure in hospital.

Heart. 1996 Nov;76(5):427-9. doi: 10.1136/hrt.76.5.427.

Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.

Heart. 1996 Feb;75(2):159-64. doi: 10.1136/hrt.75.2.159.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验